Migraine Briefs

Migraine: Repeated transcranial direct current stimulation effectively reduces pain intensity


 

Key clinical point: Repeated active transcranial direct current stimulation (tDCS) for at least 4 weeks significantly reduced migraine pain intensity and resulted in a trend for reduction in the duration of a migraine episode.

Major finding: Patients treated with active vs. sham tDCS showed a significantly higher reduction of pain intensity (mean difference [ MD], −1.44; P less than .01) and a trend for reduction in migraine duration (MD, −1.31; P = .14).

Study details: Findings are from a meta-analysis of 5 randomized controlled trials including 104 patients with migraine with/without aura and chronic migraine who received either active or sham tDCS.

Disclosures: No information on funding was available. The authors declared no conflicts of interest.

Source: Cai G et al. J Pain Res. 2021 Apr 27. doi: 10.2147/JPR.S295704 .

Recommended Reading

Combination therapy may benefit patients with migraine
Migraine ICYMI
A large proportion of migraine patients are not offered preventive treatment
Migraine ICYMI
e-TNS device passes at-home test
Migraine ICYMI
Chronic headache pain in veterans linked to suicide attempts
Migraine ICYMI
Migraine linked to more COVID-19 infections, symptoms but less health care utilization
Migraine ICYMI
Ubrogepant effective for acute migraine even with preventive monoclonal antibody therapy
Migraine ICYMI
Moving more, sitting less vital for migraine patients
Migraine ICYMI
Erenumab reduces migraine attacks and not just migraine days
Migraine ICYMI
Chronic migraine: Efficacy and safety of CGRP slightly better than botulinum toxin
Migraine ICYMI
Erenumab shows long-term promise in episodic migraine patients with prior treatment failures
Migraine ICYMI